Brief: Ngm Bio Provides Business Highlights And Reports Fourth Quarter And Full Year 2022 Financial Results
28/02/2023 22:24
Feb 28 (Reuters) - Ngm Biopharmaceuticals Inc NGM.O :
* NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS FOURTH
QUARTER
AND FULL YEAR 2022 FINANCIAL RESULTS
* Q4 EARNINGS PER SHARE VIEW $-0.52 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX94yYN
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors